La interpretación de la espirometría: ¿Dónde nos encontramos?

Archivos de Bronconeumologia

Volumn 32, Issue 9, 1996, Pages 475-482

  Diez Herranz A ^a,c   Tobal Gonzalez M ^b  

^a Centro Médico Paracelso   (Spain)

^b Enfermera   (Spain)

^c C/Puente Colgante 28   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; PREDICTION AND FORECASTING; REFERENCE VALUE; SPIROMETRY; STATISTICS;

HUMANS; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; SPIROMETRY;

EID: 0344105053     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2896(15)30709-2     Document Type: Article

References (75)

1. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: 1.202-1.218.
2. Harber P. Value based interpretation of pulmonary function tests. Chest 1985; 88: 874-877.
3. Grippi MA, Metzger LF, Krupinski AV, Fishman AP. Pulmonary function testing. En: Fishman AP, ed. Pulmonary diseases and disorders. Nueva York: McGraw-Hill Book Company, 1988; 2.469-2.521.
4. American College of Chest Physicians. Statement on spirometry. A report of the section on respiratory pathophysiology. Chest 1983; 83: 547-550.
5. Miller MR, Pincock AC. Predicted values: how should we use them? Thorax 1988; 43: 265-267.
6. Gary J, Huseby J, Culver B, Kosanke C. Variability in interpretation of pulmonary function tests. Chest 1979; 76: 389-390.
7. Roca J. Aplicaciones clínicas de las pruebas de función pulmonar. En: Ancic Cortez P, Clark THJ, eds. Enfermedades respiratorias. Utilidad del laboratorio. Santiago de Chile: Camugraf Ediciones Científicas, 1990; 171-190.
8. American Heart Association. AHA Council Report. Manual for evaluation of lung function by spirometry Circulation 1982; 65: 644A-651A.
9. Quanjer PhH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault J-C. Standardized lung function testing. Lung volumes and forced ventilatory flows. Official statement of the European Respiratory Society. Eur Respir J 1993; 6 (Supl 16): 5-40.
10. SEPAR. Normativa para la espirometría forzada. Barcelona: Ediciones Doyma S.A., 1985.
11. American Thoracic Society. Standardization of spirometry - 1994 update. J Respir Crit Care Med 1995; 152: 1.107-1.136.
12. Gindmeyer HW, Jones RN, Barkman HW, Weill H. Spirometry: quantitative test criteria and test acceptability. Am Rev Respir Dis 1987; 136: 449-452.
13. Enright PL, Johnson LR, Connett JE, Voelken H, Buist AS. Spirometry in the Lung Health Study. 1. Methods and quality control. Am Rev Respir Dis 1991; 143: 1.215-1.223.
14. Becklake MR. Concepts of normality applied to the measurement of lung function. Am J Med 1986; 80: 1.158-1.164.
15. Cotes JE. Lung function throughout life: determinants and reference values. En: Cotes JE, ed. Lung function. Assessment and application in medicine. Oxford: Blackwell Scientific Publications, 1993; 445-513.
16. Garcia JG, Hunninghake GW, Nugent KM. Thoracic gas volume measurement. Increased variability in patients with obstructive ventilatory defects. Chest 1984; 85: 272-275.
17. Humerfelt S, Eide GE, Kvåle G, Gulsvik A. Predictors of spirometric tests failure: a comparison of the 1983 and 1993 acceptability criteria from the European Community for Coal and Steel. Eur Respir J 1994; 7 (Supl 18):355S.
18. Ng'anga LW, Ernst P, Jaakkola MS, Gerardi G, Hanley JH, Becklake MK. Spirometric lung function. Distribution and determinants of test failure in a young adult population. Am Rev Respir Dis 1992; 145: 48-52.
19. 1, be reported from spirometric trials? Am Rev Respir Dis 1990; 141 (Supl): A223.
20. McKay RT. Pulmonary function testings: minimum standards versus desirable features. Am Rev Respir Dis 1989; 139 (Supl): A553.
21. Jacobs DR Jr, Nelson ET, Dontas AS, Kellen J, Slattery ML, Higgins M. Are race and sex differences in lung function explained by frame size? The CARDIA Study. Am Rev Respir Dis 1992; 146: 644-649.
22. Pennock BE, Cottrell JJ, Rogers RM. Pulmonary function testing. What is "normal"? Arch Intern Med 1983; 143: 2.123-2.127.
23. Pennock BE, Rogers RM, McCaffree DR. Changes in measured spirometric indices. What is significant? Chest 1981; 80: 97-99.
24. Miller MR, Pincock AC. Repeatability of the moments of the truncated forced expiratory spirogram. Thorax 1982; 37: 205-211.
25. Kapp MC, Schachter EN, Beck GJ, Maunder LR, Witek TJ Jr. The shape of the maximum expiratory flow volume curve. Chest 1988; 94: 799-806.
26. Enright P. Reporting the reproducibility of spirometry results. Am Rev Respir Dis 1992; 146: 1.367-1.368.
27. Ellis JH Jr, Perera SP, Levin DC. A computer program for calculation and interpretation of pulmonary function studies. Chest 1975; 68: 209-213.
28. Harber P, Schnur R, Emery J, Brooks S, Ploy-Song-Sang Y. Statistical "biases" in respiratory disability determinations. Am Rev Respir Dis 1983; 128: 413-418.
29. Sobol BJ. The early detection of airway obstruction: another perspective. Am J Med 1976; 60: 619-624.
30. Díez Herranz. Concordancia entre los valores de referencia para la espirometría recomendados por las Sociedades Neumológicas Españolas y Europea. Arch Bronconeumol 1996; 32: 459-462.
31. Díez Herranz A, Para Cabello J, Aller Álvarez JL. Interpretando la espirometría: ¿porcentajes o percentiles? Validación de diferentes criterios diagnósticos. XII Premio CIBA. Salamanca: XIV Congreso SOCALPAR, 1995.
32. Ferrante E, Anaclerio M, Quatela M, Pistelli R, Corbo GM, Fùso L et al. Reference spirometric data and their modelling: is it time to change the traditional variables in models? Eur Respir J 1994; 7 (Supl 18): 354S.
33. Viegi G, Lundbäck B, Di Pede F, Vellutini M, Pistelli F, Jonsson E et al. Comparison of forced expirograms in asymptomatic subjects of Italian and Swedish epidemiological samples. Eur Respir J 1995; 8 (Supl 19): 34S.
34. Cordero PJ, Morales P, Benlloch E, Miravet L, Cebrián J. Spirometric studies in normal subjects. Reference values for adults of Spanish descent. Eur Respir J 1995; 8 (Supl 19): 436S.
35. Ohio AJ, Crapo RO, Elliot CG. Reference equations used to predict pulmonary function. Survey at institutions with respiratory disease training programs in the United States and Canada. Chest 1990; 97: 400-403.
36. Thomas HM III, Garret RC. Interpretation of spirometry. A graphic and computational approach. Chest 1984; 86: 129-131.
37. Sobol BJ, Sobol PG. Per cent of predicted as the limit of normal in pulmonary function testing: a statistically valid approach. Thorax 1979; 34: 1-3.
38. Miller MR, Pincock AC. Predicted values: how should we use them? Thorax 1988; 43: 663-664.
39. Quanjer Phil. RV/TLC% ratio: alternative criteria of normality. Eur Respir J 1995; 8: 1.813.
40. Roberts CM, Mac Rae KD, Winning AJ, Adams L, Seed WA. Reference values and prediction equations for normal lung function in a nonsmoking white urban population. Thorax 1991; 46: 643-650.
41. Poirier KP. A quantitative definition of obstructive lung disease. Am J Med 1968; 45: 329-335.
42. Gavriely N, Nissan M, Cugell DW, Rubin A-HE. Respiratory health screening using pulmonary function tests and lung sound analysis. Eur Respir J 1994; 7: 35-42.
43. Beck KC, Offord KP, Scanlon PD. Comparison of four methods for calculating diffusing capacity by the single breath method. Chest 1994; 105: 594-600.
44. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P et al, on behalf of the Task Force. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). A consensus statement of the European Respiratory Society (ERS). Eur Respir J 1995; 8: 1.398-1.420.
45. Oliver LC, Eisen EA, Sprince NL. A comparison of two definitions of abnormality on pulmonary outcome in epidemiologic studies. Am Rev Respir Dis 1986; 133: 825-829.
46. Terrin M. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 124: 763-764.
47. Miller MR, Pincock AC. Retention of unwanted bias using percent of predicted. Am Rev Respir Dis 1987; 135 (Supl): 119A.
48. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123: 659-664.
49. Matthews DE, Farewell VT. Estadística médica. Aplicación e interpretación. Barcelona: Salvat Editores, S.A., 1990; 93-107.
50. Miller MR, Pincock AC, Grove DM. Patterns of spirogram abnormality in individual smokers. Am Rev Respir Dis 1985; 132: 1.034-1.040.
51. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 124: 764.
52. Detels R, Tashkin DP, Simmons MS, Carmichael HE Jr, Sayre JW, Rokaw SN et al. The UCLA population studies of chronic obstructive respiratory disease. 5. Agreement and disagreement of tests in identifying abnormal lung function. Chest 1982; 82: 630-638.
53. Pennock BE, Rogers RM, Owens GR, Unger KM. The normal ranges in spirometric indices. Chest 1982; 81: 658-659.
54. Oldham PD. Per cent of predicted as the limit of normal in pulmonary function testing: a statistically valid approach. Thorax 1979; 34: 569.
55. Weiss W. The normal ranges in spirometric indices. Chest 1982; 81: 658.
56. Miller MR, Grove DM, Pincock AC. Time domain spirogram indices. Their variability and reference values in nonsmokers. Am Rev Respir Dis 1985; 132: 1.041-1.048.
57. Díez Herranz A, Para Cabello J, Fernández Rodríguez ML. Validación de diversos criterios de interpretación de la espirometría forzada. Estudio preliminar. Arch Bronconeumol 1994; 30: 418-419.
58. Díez Herranz A, Teruel González FE, Aller Álvarez JL. Concordancia entre diferentes criterios de normalidad de los volúmenes pulmonares. Arch Bronconeumol 1995; 31: 43.
59. Díez Herranz A. RV/TLC% ratio: alternative criteria of normality. Eur Respir J 1995; 8: 1.812-1.813.
60. Vestbo J, Knudson KM, Rasmussen FV. The effect of smoking and occupation on lung function - a question of spirometry index and statistical methods? Am Rev Respir Dis 1989; 139 (Supl): A545.
61. Eliasson O, Degraff AC Jr. The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Influence of clinical diagnosis, spirometric, and anthropometric variables. Am Rev Respir Dis 1985; 132: 858-864.
62. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJM. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992; 146: 935-940.
63. Brugman TM, Morris JF, Temple WP. Comparison of lung volume measurements by single breath helium and multiple breath nitrogen equilibration methods in normal subjects and COPD patients. Respiration 1986; 49: 52-60.
64. Cotes JE. Lung function in disease. En: Cotes JE, ed. Lung function. Assessment and application in medicine. Oxford: Blackwell Scientific Publications, 1993; 514-609.
65. Gilbert R, Auchincloss JH. What is a "restrictive" defect? Arch Intern Med 1986; 146: 1.779-1.781.
66. Cottrell JJ, Pennock BE, Rogers RM. A simplified computer report. Towards an understandable pulmonary function test. Chest 1983; 84: 158-160.
67. Gilbert R, Auchincloss JH. The interpretation of the spirogram. How accurate is it for "obstruction"? Arch Intern Med 1985; 145: 1.635-1.639.
68. American Thoracic Society. Evaluation of impairment/disability secondary to respiratory disorders. Am Rev Respir Dis 1986; 133: 1.205-1.209.
69. Oliver LC, Eisen EA, Sprince NL. Effects of definition criteria on outcome in epidemiologic studies. Am Rev Respir Dis 1985; 131 (Supl): A175.
70. Gilbert R, Auchincloss JH, Belotti D, Peppi D. Spirometric diagnosis of airway obstruction. Am Rev Respir Dis 1983; 127 (Supl): 119A.
71. 22-75 percent. Chest 1983; 84: 473-474.
72. Cotes JE. Assessment of bellows and mechanical attributes of the lung. En: Cotes JE, ed. Lung function. Assessment and application in medicine. Oxford: Blackwell Scientific Publications, 1993; 131-178.
73. Coates AL, Desmond KJ, Demizio D, Allen P, Beaudry PH. Sources of error in flow-volume curves. Effect of expired volume measured at the mouth vs that measured in a body plethysmograph. Chest 1988; 94: 976-982.
74. Pavlov N, Tocilj J. Sensitivity and specificity of spirometry and maximal expiratory flow-volume curve in asthmatic and healthy children. Eur Respir J 1995; 8 (Supl 19): 130S.
75. Colp CR. Interpretation of pulmonary function tests. Chest 1979; 76: 377-378.